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Abstract 
Endometriosis is a complex gynaecological condition affecting approximately 2-17% of 
women. The abnormal growth of endometrial tissue outside the uterus often results in chronic 
pelvic pain, dysmenorrhoea, dyspareunia, fatigue and infertility. Several theories attempt to 
explain the aetiology of endometriosis, but its exact origin remains incomplete. Treatments aid 
in supressing symptoms but no cure is currently available. Endometriosis has significant 
psychosocial impact on women, leaving them susceptible to poor mental health and reduced 
quality of life. This review will explore the aetiology, symptoms and treatments for 
endometriosis, and discuss the impact of endometriosis on the psychosocial wellbeing of 
affected women.   
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Introduction 
Endometriosis is an estrogen-dependent, chronic inflammatory gynaecological 
condition that affects women of reproductive age (Kennedy et al., 2005). It is characterised 
by endometrial tissue (cells lining the uterus) growing outside the uterus (Eriksen et al., 2008; 
Giudice, 2010; Kennedy et al., 2005). This abnormal growth can be found anywhere in the 
body, however, the most common locations are on the pelvic peritoneum, ovaries, and 
rectovaginal septum (Giudice, 2010). Rarer sites include the diaphragm, pleura, and 
pericardium (Giudice, 2010). Classic presentation of endometriosis includes chronic pelvic 
pain, fatigue, dysmenorrhoea (menstrual pain), heavy menstrual bleeding, dyspareunia 
(painful intercourse) and infertility (Laganà et al., 2017; Pope, Sharma, Sharma, & 
Mazmanian, 2015). The prevalence of endometriosis is difficult to determine because 
definitive diagnosis can only be established using laparoscopy (Pope et al., 2015). However, 
based on community prevalence of symptoms, endometriosis has been estimated to affect 
between 2% and 17% of the female population (Bernuit et al., 2011; Culley et al., 2013), 
totalling approximately 176 million women worldwide (Adamson, Kennedy, & Hummelshoj, 
2010). The precise aetiology of endometriosis remains unknown, making diagnosis difficult. 
As a result, endometriosis is often associated with diagnostic delay, leading to frustration, 
which in turn contributes to poorer mental health and reduced quality of life in affected 
women (Sepulcri & do Amaral, 2009). Endometriosis is incurable with available treatments 
focusing on symptom management, especially pain reduction. Studies demonstrate a 
considerable adverse impact of endometriosis on women’s quality of life and psychological 
wellbeing, with pain playing a central role (Facchin et al., 2015; Lorençatto, Alberto Petta, 
José Navarro, Bahamondes, & Matos, 2006). 
Endometriosis is not only a burden for the individual woman affected but also 
presents as a burden for society in economic terms. Endometriosis is associated with 
PSYCHOSOCIAL RISK FACTORS FOR DEPRESSION IN ENDOMETRIOSIS 10 
 
substantial indirect and direct economic costs (Simoens et al., 2012). The annual healthcare 
expenditure in relation to endometriosis is comparable to other significant health conditions 
such as diabetes, Crohn’s disease and rheumatoid arthritis (Marinho et al., 2018; Simoens et 
al., 2012). On average, the annual cost of endometriosis has been estimated to be €9579 per 
woman (95% CI: €8559-€10599; (Simoens et al., 2012)) when both direct and indirect costs 
are considered. The indirect costs of productivity loss account for more than half of the costs 
at €6298 (Simoens et al., 2012). The direct costs are comprised of health care costs and non-
health care costs. Surgery is the most expensive item among health care costs (29% of health 
care costs), while medication constitutes 10% of health care costs (Simoens et al., 2012).  
 To better appreciate the extent to which endometriosis affects women, it is beneficial 
to understand the medical aspects of endometriosis. Thus, the first part of this review will 
explore the diagnosis of endometriosis, some of the theories that attempt to explain its origin, 
treatment options, and the physical symptomatic presentation of endometriosis. The second 
part will review the literature on the impact of endometriosis on mental health, specifically 
depression and anxiety, intimate relationships, education and employment, and quality of life. 
Finally, suggestions for future research will be discussed.  
Diagnosis and Classification of Endometriosis 
The diagnostic gold standard for endometriosis is laparoscopic visualisation (Hsu, 
Khachikyan, & Stratton, 2010). The revised endometriosis classification system of the 
American Society for Reproductive Medicine is widely utilised to determine disease stage 
(Stage I: minimal disease - Stage IV: severe disease) based on type, location, appearance and 
depth of lesion invasion (American Society for Reproductive Medicine, 1997; Giudice, 
2010). Even though staging of endometriosis is useful for determining disease burden and 
treatment, stages and locations of endometriosis do not correlate with pain severity, nor can 
they predict response to treatment for pain or infertility (Giudice, 2010; Lorençatto et al., 
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2006). This means that women with mild endometriosis may present with intense pelvic pain 
and women with severe endometriosis may experience less or no pelvic pain (Eriksen et al., 
2008; Laganà et al., 2017). Women with endometriosis often experience a significant delay 
between the onset of symptoms and the final diagnosis of endometriosis (Bernuit et al., 2011; 
Fourquet et al., 2010; Nnoaham et al., 2011; Sepulcri & do Amaral, 2009), ranging from five 
(Sepulcri & do Amaral, 2009) to nearly nine years (Fourquet et al., 2010). The delay occurs 
at both patient and primary health care levels (Ballard, Lowton, & Wright, 2006). At the 
patient level, women have been found to delay seeking medical assistance. On average, it 
takes women 3.8 years to seek medical assistance once they experience symptom onset (Cox, 
Henderson, Andersen, Cagliarini, & Ski, 2003). Various factors have been proposed to 
explain why women fail to seek early medical assistance. Women may struggle to distinguish 
between normal and pathological symptoms, they may consider themselves “unlucky” rather 
than “unwell”, and they may fear embarrassment and being perceived as weak (Ballard et al., 
2006; Cox et al., 2003). In addition, the perception of menstrual irregularities and pain as 
“normal” also contributes to women’s delay in help-seeking behaviour (Ballard et al., 2006; 
Cox et al., 2003). 
Delays also occur at the primary health care level with time between help-seeking and 
diagnosis lasting up to 5.7 years (Elaine Denny & Mann, 2008). Primary health care 
professionals may be reluctant to refer women for further investigation, leading to delay in 
formal diagnosis (Elaine Denny & Mann, 2008; Nnoaham et al., 2011). Women report an 
average of seven visits to primary care before obtaining a specialist referral (Nnoaham et al., 
2011). Research suggests that women frequently experience normalisation of symptoms, and 
symptoms being dismissed and/or trivialised during their repeated consultations with doctors 
(Ballard et al., 2006; Elaine Denny & Mann, 2008). Many women are misdiagnosed, most 
commonly with irritable bowel syndrome (IBS) and pelvic inflammatory disease, and upon 
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referral, they are initially referred to incorrect secondary care (Ballard et al., 2006; Elaine 
Denny & Mann, 2008).  
Aetiology of Endometriosis 
The aetiology of endometriosis is still unknown. Several theories on the development 
of endometriosis have been proposed however including theories of retrograde menstruation, 
coelomic metaplasia, and lymphatic and vascular metastasis. Other potential factors in the 
pathology of endometriosis include genetics, immunology, and environmental and lifestyle 
factors. While these major theories have led to the discovery of factors involved in the 
development of endometriosis, they have been difficult to support and thus remain 
inconclusive.   
Retrograde Menstruation 
The theory of retrograde menstruation and implantation (Sampson, 1927) is the most 
accepted theory of how endometrial tissue makes its way into the peritoneal cavity. The 
theory suggests that the pathology of endometriosis develops when endometrial tissue is shed 
from the mucosa of the uterus and migrates back through the fallopian tubes and into the 
abdomen where it implants and proliferates (Sampson, 1927). Sampson (1927) also proposed 
that endometrial tissue grows outside of the uterus because the tissue is absorbed into venous 
circulation during menstruation. Retrograde menstruation occurs in up to 90% of 
menstruating women (Bokor et al., 2009; Burney & Giudice, 2012); however, not all women 
with retrograde menstruation have endometriosis (Giudice, 2010). It has been suggested that 
affected women may have an immune dysfunction that interferes with clearing of the lesions, 
giving rise to endometriosis (Giudice, 2010).  
Coelomic Metaplasia 
The theory of coelomic metaplasia includes the potential morphological changes of 
cells that exist in the ovary. The potential for metaplasia exists because both the ovary and 
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uterus have cells that derive from the same precursor cell (Vinatier, Orazi, Cosson, & Dufour, 
2001). However, some aspects remain unexplained by this theory. First, if the origin of 
endometriosis is explained by peritoneal metaplasia, then a similar condition ought to be 
observed in males (Vinatier et al., 2001). Second, coelomic metaplasia would be observed in 
all tissues derived from coelomic epithelium, including striated and smooth muscle, the heart, 
the blood and lymphatic vessels, the spleen, kidneys and the adrenal cortex (Ross & Pawlina, 
2011). Finally, endometriosis should be more widespread in older women if coelomic 
metaplasia mirrors usual metaplasia (Ross & Pawlina, 2011).  
Lymphatic and Vascular Metastasis 
The theory of lymphatic and vascular metastasis (Vinatier et al., 2001) suggests that 
parts of endometrial tissue are absorbed into lymphatic spaces between muscle bundles of the 
uterine wall and are transported to superficial lymphatics. This occurs during the invasion of 
the myometrium by its mucosa (Vinatier et al., 2001). The theory of lymphatic and vascular 
metastasis potentially explains distant lesions as endometrial tissue is taken up by the blood 
supply and lymphatic vessels in the uterus and transported to other parts of the body 
(Giudice, 2010; Vinatier et al., 2001). However, this does not explain the particular location 
of most endometrial lesions: the surface of the ovaries and within the abdominal peritoneum.  
Environmental and Lifestyle Factors 
Dietary factors and environmental toxins are potentially linked to the development 
and progression of endometriosis (Bellelis, Podgaec, & Abrão, 2011; Missmer et al., 2010). 
Through diet, humans are exposed to environmental toxins that potentially disrupt 
physiological processes and lead to the development of endometriosis (Bellelis et al., 2011; 
White & Birnbaum, 2009). Endocrine disruption occurs because environmental toxins alter 
steroid synthesis or hormone receptor function, disrupt immune function, and inhibit 
reproductive function by epigenetic modifications (Bruner-Tran, Yeaman, Crispens, Igarashi, 
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& Osteen, 2008). High consumption of red meat and trans-fat is associated with increased 
risk of endometriosis, whereas eating fruits, green vegetables, and n-3 long chain fatty acids 
is associated with decreased risk (Missmer et al., 2010). The risk of developing estrogen-
dependent diseases such as breast cancer and endometriosis has been shown to be increased 
by alcohol consumption (Seitz, Pelucchi, Vecchia, & Bagnardi, 2012; Singletary & Gapstur, 
2001). Several studies have investigated the correlation between alcohol consumption and the 
risk of developing endometriosis with conflicting results (Hemmings et al., 2004; Nagle et 
al., 2009). A systematic review and meta-analysis on alcohol consumption and endometriosis 
risk confirmed that an association exists between alcohol intake and risk of endometriosis 
(Parazzini et al., 2013). However, there is not sufficient evidence to conclude a significant 
role of environmental toxins and dietary factors in endometriosis aetiology.  
Treatment of Endometriosis 
As no cure for endometriosis exists, long-term treatment of endometriosis primarily 
focuses on pain reduction obtained through medical or surgical treatments, or a combination 
of these two approaches (Giudice, 2010). Individuals often also seek out a range of 
complementary treatments. 
Medical treatments 
Medical treatment is typically initiated for pain reduction without surgical 
confirmation (Giudice, 2010). Pain reduction is obtained through minimising inflammation, 
interrupting or suppressing cyclic ovarian hormone production, inhibiting the action and 
synthesis of estrogen, and reducing or eliminating menstruation (Giudice, 2010). To relieve 
dysmenorrhea, medical professionals commonly prescribe nonsteroidal anti-inflammatory 
drugs (NSAIDs) on their own or in combination with cyclical, or continuous use of, 
combined oral contraceptives (Giudice, 2010; Kennedy et al., 2005). Overall, a systematic 
review showed that GnRH agonists, progestins, oral contraceptives and Danazol were 
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effective treatment modalities for endometriosis (Jia, Leng, Shi, Sun, & Lang, 2012). These 
treatment modalities have also been strongly associated with improvement in women’s 
health-related quality of life (HRQoL; (Burry, 1992; Harada et al., 2009; Sesti et al., 2007; 
Vercellini et al., 2002)). 
Surgical treatments 
Surgical procedures include conservative and radical surgery. Conservative surgery 
such as excision or laser ablation of endometrial implants has shown to improve HRQoL in 
women diagnosed with endometriosis (Abbott et al., 2004; Mabrouk et al., 2011; Roman, 
2010; Vercellini et al., 2003). A randomised control trial demonstrated that laparoscopic 
excision was more effective in reducing pain and improving HRQoL and sexual activity than 
placebo treatment (Abbott et al., 2004). It is noteworthy, however, that a 30% placebo 
response rate was observed (41). Radical surgery for endometriosis involves the elimination 
of all possible endometriosis implants in the pelvic and abdominal cavity and includes 
hysterectomy and bilateral adnexectomy (De la Hera-Lazaro et al., 2016). 
Complementary treatments 
Complementary treatments may include homeopathy, dietary supplementation, 
acupuncture, progressive muscle relaxation (PMR) and Chinese herbal medicine (CHM). A 
randomised, sham-controlled trial showed that Japanese-style acupuncture was effective for 
endometriosis-related pain (Wayne et al., 2008). In terms of HRQoL, dietary supplementation 
after conservative surgery yielded greater improvement compared to surgery alone (Sesti et 
al., 2007). While a randomised control trial demonstrated the effectiveness of PMR training 
in improving anxiety, depression and HRQoL in women with endometriosis undergoing 
hormonal suppression therapy (Zhao et al., 2012). Regular gentle exercise and proper 
nutrition are generally recommended as alternative therapies (Fromer, 1998); however, data 
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from large, randomised controlled trials are lacking to confirm the effectiveness of such 
recommendations.  
Impact of Endometriosis on Physical Health 
Painful symptoms caused by endometrial implants that proliferate and bleed in 
conjunction with hormonal cycles are the most common characteristics of endometriosis 
(Giudice, 2010). Dysmenorrhoea is the most frequently reported symptom of endometriosis 
(50-90% of cases; (Giudice, 2010). Other pain symptoms include dyspareunia, lower 
abdominal and back pain, bowel and ovulation pain (Giudice, 2010). Pelvic pain due to 
endometriosis is typically chronic (lasting six months or longer), and can be dull, throbbing, 
or sharp in nature. Pain can occur unpredictably and irregularly throughout the menstrual 
cycle, or it can be continuous, and can in some cases be exacerbated by physical activity 
(American Society for Reproductive Medicine, 2014). Additional commonly reported 
symptoms include heavy menstrual flow, bloating, fatigue, infertility (up to 50% of women), 
and urinary and defecatory dysfunctions (Kennedy et al., 2005). Bladder- and bowel-related 
symptoms are usually cyclic (American Society for Reproductive Medicine, 2014). 
Symptoms overlap with several gynaecological conditions (e.g., pelvic inflammatory disease 
and ovarian cysts) and non-gynaecological conditions (e.g., IBS; (Giudice, 2010)), making 
diagnosis difficult. Considering the physical symptoms of endometriosis, the associated 
diagnostic delays, unknown aetiology and incurable nature, it is unsurprising that women 
diagnosed with endometriosis become more susceptible to poor mental health and reduced 
quality of life (Sepulcri & do Amaral, 2009).  
Impact of Endometriosis on Psychosocial Wellbeing 
Endometriosis has significant psychosocial impact on affected women (Culley et al., 
2013). A thematic analysis revealed key categories of impact: diagnostic delay and 
uncertainty, quality of life and everyday activities, intimate relationships, planning for and 
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having children, education and work, mental health and emotional wellbeing, and medical- 
and self-management (Culley et al., 2013). It is noteworthy that pain arose as a significant 
symptom across these categories (Culley et al., 2013). Categories such as diagnostic delay, 
uncertainty relating to the cause of disease, and management of disease have been explored in 
earlier sections of this literature review. The following sections will elaborate on mental 
health, specifically depression and anxiety, intimate relationships, and education and 
employment and quality of life.  
Anxiety and Depression 
Overall, studies report higher rates of anxiety, depression and emotional distress in 
women with endometriosis compared to healthy controls and the general population 
(Fourquet, Báez, Figueroa, Iriarte, & Flores, 2011; Lorençatto et al., 2006; Petrelluzzi, 
Garcia, Petta, Grassi-Kassisse, & Spadari-Bratfisch, 2008; Sepulcri & do Amaral, 2009; 
Siedentopf, Tariverdian, Rucke, Kentenich, & Arck, 2008; Simoens et al., 2012). The 
prevalence of moderate to severe anxiety and depression in a sample of women with 
endometriosis was 29% and 14.5%, respectively (Friedl et al., 2015). This is an odds ratio of 
three compared to prevalence in the general population (general population, anxiety: 8-10%; 
depression: 4-6% (Friedl et al., 2015)). Additionally, the elevated prevalence of anxiety and 
depression in women with endometriosis has been found to be comparable to other chronic 
somatic conditions (Friedl et al., 2015).  
Findings regarding the role of pain in poor mental health are inconsistent when 
comparing women with endometriosis and pain to women with endometriosis without pain 
(Eriksen et al., 2008; Lorençatto et al., 2006; Sepulcri & do Amaral, 2009). Lorenҫatto et al. 
(2006) compared the prevalence of depression in women diagnosed with endometriosis and 
pelvic pain to women diagnosed with endometriosis without pelvic pain. Depression was 
found in 86% of women with endometriosis and pelvic pain (mild depression: 34%; 
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moderate/severe depression: 52%) compared to 36% in women with endometriosis without 
pelvic pain (mild depression: 24%; moderate/severe depression: 14%) (Lorençatto et al., 
2006). This suggests that the experience of pain is a risk factor for depression in women with 
endometriosis. However, it is unclear whether the assessors were blinded to the presence or 
absence of pain in women, introducing possible bias to the study’s findings. The authors 
posited that longer periods of pain could potentially lead to higher degrees of pain, and they 
anticipated higher degrees of pain to be correlated with higher depression scores (Lorençatto 
et al., 2006). Consistent with the findings of Lorenҫatto et al. (2006), Sepulcri and do Amaral 
(2009) found anxiety and depression to be highly prevalent in women with endometriosis and 
pelvic pain. Out of the 104 women participating, 87.5% reported anxiety (minor anxiety: 
24%, major anxiety: 63.5%) and 86.5% showed depressive symptoms (mild depression: 
22.1%, moderate: 31.7%, severe: 32.7% (Sepulcri & do Amaral, 2009)). However, no 
significant correlation was found between pain severity and anxiety and depression, 
disagreeing with the predictions of Lorenҫatto et al. (2006). 
Contrastingly, Friedl et al. (2015) found the impact of endometriosis to be less than 
what is reported in other studies. They found moderate to severe anxiety in 29% of women 
with endometriosis, and depressive symptoms in 14.5% of women (Friedl et al., 2015). 
Interestingly, Eriksen et al. (2008) were not able to confirm previous findings related to the 
association between higher anxiety and depression scores in women with endometriosis and 
pain compared to women with endometriosis without pain. Upon comparing women with 
endometriosis according to the presence or absence of pain, no significant differences in 
anxiety and depression scores were found between the two groups (Eriksen et al., 2008). As 
with several other studies, no correlation between the stage of endometriosis, pain and 
psychiatric symptoms was reported (Eriksen et al., 2008; Sepulcri & do Amaral, 2009; 
Tripoli et al., 2011). Friedl et al. (2015) did, however, find women’s age to influence their 
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mental health with advanced age being significantly related to better mental health. A 
plausible explanation for this is that women who can integrate endometriosis into their daily 
life feel less stressed and have less frequent affective symptoms (Friedl et al., 2015). When 
comparing women with chronic pelvic pain due to endometriosis to women with chronic 
pelvic pain from pathologies other than endometriosis, it becomes clear that the experience of 
pain is associated with mental health difficulties and emotional stress (Low, Edelmann, & 
Sutton, 1993; Roth, Punch, & Bachman, 2011; Souza et al., 2011; Waller & Shaw, 1995). 
Qualitative studies emphasise emotional distress as a key feature for women with 
endometriosis, including feelings of isolation, hopelessness, guilt, worry, worthlessness, and 
feeling suicidal (Cox et al., 2003; Moradi, Parker, Sneddon, Lopez, & Ellwood, 2014; 
Roomaney & Kagee, 2018; Whelan, 2007).  
Impact on Intimate Relationships 
Incapacitating pain and dyspareunia have been found to adversely impact the quality 
of women’s intimate relationships, with up to 71% of women reporting that endometriosis 
negatively affects their sexual behaviour (Fourquet et al., 2011). Dyspareunia often leads to 
women either suffering pain during sexual intercourse, stopping intercourse with their partner 
after it has been initiated, or being completely unable to engage in penetrative sex (E. Denny 
& Mann, 2007; Huntington & Gilmour, 2005; Jones, Jenkinson, & Kennedy, 2004b). For 
69% of women, dyspareunia has led to pain hours and even days after sexual intercourse (E. 
Denny & Mann, 2007). The majority of women who experience dyspareunia subsequently 
avoid or have less frequent sexual intercourse compared to women with asymptomatic 
endometriosis and healthy controls (E. Denny & Mann, 2007; Jones et al., 2004b; Tripoli et 
al., 2011). Research demonstrates that women feel that endometriosis (including but not 
limited to dyspareunia) negatively affects their relationships and has in some instances 
contributed to relationship breakdown (Cox et al., 2003; Fagervold, Jessen, Hummelshoj, & 
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Moen, 2009). In terms of fertility, Jones et al. (2004b) reported that infertility, or concerns 
regarding infertility, led to worry, depression, feelings of inadequacy among women, and 
contributed to relationship breakdown. In contrast, other studies have found no correlation 
between infertility and adverse effects on relationships (Fagervold et al., 2009).  
Impact on Education and Employment 
Findings are inconclusive in regards to the impact of endometriosis on education. 
Some studies have shown that women’s study activity and grades were affected by 
endometriosis, and some women have left education before completion because of 
endometriosis (Gilmour, Huntington, & Wilson, 2008). Contrastingly, other studies found 
that only a minority of women report that they have experienced negative consequences of 
endometriosis on their education (Fagervold et al., 2009).  
The evidence is more consistent when it comes to the impact of endometriosis on 
employment. Endometriosis has been associated with losses in work productivity with 
increased disease severity leading to increased loss in productivity (Fourquet et al., 2011; 
Nnoaham et al., 2011; Tripoli et al., 2011). When symptoms are at their worst, women on 
average miss 7.41 hours of work per week and miss 19.3 days of work per year (Fourquet et 
al., 2010). Nnoaham et al. (2011) found a similar trend with a loss of 10.8 hours per week. 
This was however, primarily attributed to a reduction in effectiveness at work (presenteeism), 
as opposed to time lost from work (absenteeism) (Nnoaham et al., 2011). Other research 
suggests that symptoms of endometriosis, especially pelvic pain, affect work productivity 
with 23% to 66% of women reporting that their ability to carry out work-related activities is 
limited by their symptoms (Bernuit et al., 2011; Fourquet et al., 2011; Fourquet et al., 2010). 
Women with endometriosis have been found to report both greater absenteeism and 
presenteeism compared to women with suggestive symptoms but no endometriosis 
(symptomatic controls; (Nnoaham et al., 2011)). As a result, full-time employment may be in 
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jeopardy for some endometriosis-affected women because of increased workplace absence 
(Gilmour et al., 2008). Some women have expressed that they feel limited to part-time 
employment because it facilitates the management of their condition much easier than full-
time employment (Gilmour et al., 2008).  
Quality of Life 
Quality of life is a multidimensional construct that incorporates physical, 
psychological and social aspects of an individual’s position in their life (World Health 
Organisation, 2018). Numerous studies on the quality of life in women diagnosed with 
endometriosis have yielded conflicting results. 
 Some research has demonstrated that being diagnosed with endometriosis is enough 
to significantly affect women’s quality of life (Elaine Denny, 2009). Living with 
endometriosis, whether symptomatic or pain-free, impairs women’s quality of life because of 
the associated uncertainty regarding the course of the disease and the future in general, 
including concerns about sexuality and infertility (Elaine Denny, 2009). Results from 
qualitative research indicate that the mere awareness of living with endometriosis is 
associated with negative feelings, such as being sick, different, and an incomplete woman 
(Elaine Denny, 2009). Likewise, studies comparing women with endometriosis to 
symptomatic controls show that women with endometriosis have poorer quality of life than 
symptomatic controls (Centini et al., 2013; Nnoaham et al., 2011). This implies that the 
diagnosis of endometriosis is a major contributing factor to reduced quality of life.  
Contrastingly, other research implies that endometriosis in itself is not necessarily 
associated with poorer quality of life and psychological health (Facchin et al., 2015). Instead, 
the presence of pelvic pain seems to be the determining factor for substandard quality of life 
and poor mental health. One study examined the impact of endometriosis on quality of life, 
anxiety and depression by comparing women with asymptomatic endometriosis, women with 
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endometriosis and pelvic pain, and healthy, pain-free controls (Facchin et al., 2015). 
Significant between-group effects were found with medium to large effect sizes. 
Endometriosis with pelvic pain was associated with poorer quality of life and higher anxiety 
and depression scores compared to the two other conditions. No significant differences were 
found between women with asymptomatic endometriosis and the control group (Facchin et 
al., 2015), suggesting that it is not endometriosis per se that gives rise to poorer quality of life 
and mental health. Instead, the experience of pain seems to play a vital role.  
Similarly, in an integrative review of quality of life in women with endometriosis, 
women with endometriosis were found to have poorer quality of life compared to healthy or 
asymptomatic controls (Marinho et al., 2018). Endometriosis had an adverse impact on all 
domains of quality of life, however, this was related more to symptoms than diagnosis as 
such. Most studies included in the review failed to demonstrate a difference in quality of life 
between women with endometriosis and women with chronic pelvic pain due to other causes, 
showing that pain symptoms in particular play a significant role in deteriorating quality of life 
(Marinho et al., 2018). Additionally, chronic pelvic pain was found to be independently 
associated with poor quality of life, whereas endometriosis in itself was not (Marinho et al., 
2018). Consistent with the review by Marinho et al. (2018), a systematic review on health-
related quality of life (HRQoL) in women with endometriosis concluded that HRQoL was 
impaired in women with endometriosis, and this was primarily due to symptoms like pelvic 
pain (Jia et al., 2012). 
Much like findings with anxiety and depression, quality of life has been found to be 
positively affected by age (Lövkvist, Boström, Edlund, & Olovsson, 2016). Affected women 
under 30 years of age reported more disease-related problems than women above 40 years of 
age, with lower scores in the quality of life domains relating to role-physical, social 
functioning, role-emotional and mental health (Lövkvist et al., 2016). Perhaps older women 
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have developed more effective coping mechanisms, despite younger women having been 
shown to use coping strategies more frequently (Lövkvist et al., 2016). The correlation may 
be partially explained by more severe symptoms occurring in early-onset disease, by 
decreasing hormonal levels with aging, by older women having more time to engage in 
disease management, or a combination of such factors (Marinho et al., 2018). 
In regards to infertility and quality of life, it has been found that women with 
infertility due to endometriosis have lower HRQoL and higher perceived stress levels than 
women with idiopathic infertility (Siedentopf et al., 2008).  
Development of Poorer Psychosocial Wellbeing 
One framework that can be used to understand the relationship between endometriosis 
and the development of poorer psychosocial wellbeing is the biopsychosocial model. The 
biopsychosocial model provides a holistic understanding of health and illness as it considers 
the biological (e.g., genetic predisposition, pain symptoms), psychological or behavioural 
(e.g., depression, lifestyles), and social factors (e.g., relationships, education level) in the 
varying stages of pathogenesis and health aetiology (see Figure 1) (Engel, 1977; Hatala, 
2012). Chronic pelvic pain often affects the psychosocial functioning of endometriosis-
affected women (Laganà et al., 2017; Lorençatto et al., 2006), and high levels of depression 
have been demonstrated to amplify the severity of pain (Laganà et al., 2017). Thus, as 
explained by the biopsychosocial model, components across the different realms contribute to 
women’s experience of endometriosis. Therefore, if interventions do not address each of the 
biopsychosocial components of endometriosis, then the vicious circle of chronic pelvic pain 
and poor psychosocial functioning (psychopathological disease → increased pain → 
worsening of psychopathological disease) is maintained (Laganà et al., 2017). Hence, 
adopting a multidisciplinary approach in the management of endometriosis is vital in order to 
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more studies comparing the impact of endometriosis with and without infertility on mental 
health are warranted to gain a better understanding of the relationship between infertility and 
endometriosis. Systematic reviews on the impact of endometriosis on mental health and 
quality of life exist, however, no systematic review has attempted to identify risk factors for 
poorer mental health and substandard quality of life among women with endometriosis. 
Given the high prevalence of depression among women with endometriosis and considering 
the impact of depression on quality of life, future research ought to collate the existing 
literature on depression in order to identify potential risk factors for depression among 
women with endometriosis. Such research would contribute to the existing literature by 
highlighting factors that should be clinically screened and targeted in interventions.  
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Condensation: Endometriosis-affected women who experience anxiety, chronic pelvic pain 
and dysmenorrhea are more vulnerable to developing depression. 
 
Short title: Psychosocial risk factors for depression in endometriosis.  
 
AJOG at a Glance:  
A. Why was this study conducted? 
This systematic review and meta-analysis was conducted because sparse research has 
examined potential psychosocial risk factors for depression, a condition which is 
highly prevalent in endometriosis-affected women.  
 
B. What are the key findings? 
Anxiety, chronic pelvic pain, and dysmenorrhea were found to be clinically 
significant psychosocial risk factors for depression. 
 
C. What does this study add to what is already known? 
This review adds to the existing literature by providing an overview of psychosocial 
risk factors for depression among endometriosis-affected women. Additionally, the 
findings of this review emphasise the importance of early screening so that women at 
greater risk of developing depression can be identified and psychological support 
offered in a timely manner. 
 
Keywords: anxiety; chronic pelvic pain; depression; dysmenorrhea; endometriosis; mental 
health; meta-analysis; psychological well-being; risk factor; systematic review. 




Existing literature indicates that endometriosis-affected women may suffer poorer 
psychological wellbeing with depression being highly prevalent. Despite the high prevalence, 
sparse research has examined potential psychosocial risk factors for depression. Thus, the 
objective of this systematic review and meta-analysis was to summarise existing research on 
psychosocial risk factors for depression among women with endometriosis in order to identify 
areas for clinical assessment and/or intervention.  
Data Sources 
PubMed, PsycINFO, Web of Science, CINHAL, and Embase were systematically searched 
from database commencement to September 2018.  
Study Eligibility Criteria 
Studies were eligible for inclusion if they met the following criteria: full-text original article 
published in the English language, diagnosis of endometriosis clinically or histologically 
based, depression measured using recognised and validated self-report or clinician-based 
instruments, psychosocial risk factors for depression were evaluated in at least two studies, and 
sufficient statistical data to calculate effect sizes was provided. Studies reporting data from 
multivariate analyses were excluded.  
Study Appraisal and Synthesis Methods 
Two reviewers assessed the studies. Assessment of risk of bias was carried out using the Joanna 
Briggs Institute (JBI) critical appraisal tool for analysing cross-sectional studies. 
Disagreements were resolved through discussion. Effect sizes were calculated and pooled 
through meta-analysis.  
Results 
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Seven psychosocial risk factors were identified across nine cross-sectional studies (866 
women). The psychosocial risk factors were: age, education, marital status, chronic pelvic pain, 
dysmenorrhea, and dyspareunia. Only anxiety (r = .662), chronic pelvic pain (r = .333), and 
dysmenorrhea (r = .408) were clinically significant psychosocial risk factors for depression.  
Conclusions 
These results suggest that endometriosis-affected women who experience anxiety, chronic 
pelvic pain and dysmenorrhea are more vulnerable to developing depression. Based on these 
results, early screening for anxiety, chronic pelvic pain and dysmenorrhea are encouraged such 
that psychological support can be incorporated into endometriosis treatment plans in a timely 
manner. Further primary research examining psychosocial risk factors for depression among 
women with endometriosis is recommended in order to draw more firm conclusions about the 
risk factors identified in the current research and to determine other potential psychosocial and 
endometriosis-related risk factors for depression in this population.  
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Introduction 
Endometriosis is a gynaecological condition that is characterised by the presence of 
endometrial tissue outside the uterus, typically found in the abdominal cavity and its 
surrounding locations (1). The abnormal growth of endometrial tissue results in an estrogen-
dependent chronic inflammatory response that is usually associated with chronic pelvic pain, 
dysmenorrhea, dyspareunia and infertility (2-4). Endometriosis is estimated to affect 2-17% 
of women, making it one of the most common gynaecological conditions among women of 
reproductive age (5-7).  
Laparoscopic evaluation with subsequent histopathological analyses of biopsies is the 
gold standard for a definitive diagnosis of endometriosis(8, 9). The aetiology of 
endometriosis remains controversial; however, several theories have been proposed asserting 
the influence of immune dysfunction, and genetic and environmental factors in the 
development of endometriosis (10). The severity of endometriosis can vary from mild to 
severe with its classification determined by the American Society of Reproductive Medicine 
(9). Stage I and II represent initial stages of endometriosis, whereas stage III and IV represent 
advanced stages (11). Pain symptoms of endometriosis have been reported to be independent 
of the location and stage of disease, meaning that some women with severe endometriosis 
may be asymptomatic while some women with mild endometriosis may present with severe 
pain (1, 12, 13).  
Besides physical symptoms, women with endometriosis may also experience 
disturbances in relationships and employment (14-16) as endometriosis has been shown to 
reduce quality of life and impair the mental health of affected women (4). Depression, the 
focus of the current review, in particular, has been shown to be a key psychological 
consequence of endometriosis (4, 17, 18). 
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For a diagnosis of Major Depressive Disorder (MDD) five or more depressive 
symptoms must have been present for a minimum of two weeks (19). Depressed mood and/or 
loss of interest or pleasure must be present along with three to four other symptoms (19). 
Such symptoms include changes in weight and appetite, insomnia or hypersomnia, 
psychomotor agitation or retardation, fatigue, feelings of worthlessness or excessive or 
inappropriate guilt, diminished ability to think or concentrate or make decisions, recurrent 
thoughts of death or suicidality (19). It is, however, important to note that one can experience 
depressive symptoms without meeting the full criteria for a diagnosis of MDD. Hence, for 
this review, an inclusive approach was adopted to include women with endometriosis who 
experience depressive symptoms.  
The prevalence of depression in women with endometriosis has been examined across 
several studies (12, 20-23). Findings from existing research on the relationship between 
endometriosis and depression have been inconsistent (12, 18, 24-26). Some research 
comparing endometriosis patients with healthy controls have not found a significant 
difference in the prevalence of mood disorders between the two groups (27), suggesting that 
endometriosis does not significantly impair the mental health of affected women. Contrary, 
other, more recent, studies have demonstrated that both symptomatic and asymptomatic 
endometriosis can give rise to poor mental health (1, 12, 25). Interestingly, Eriksen et al. (1) 
were unable to detect a significant difference in depression levels between women with 
symptomatic and asymptomatic endometriosis. This suggests that pain symptoms are not the 
only factors that contribute to the development of depression in women with endometriosis. 
However, the majority of studies report elevated levels of depression in women with 
endometriosis who experience pain compared to women with asymptomatic endometriosis 
(17, 21, 25). For example, Lorenҫatto et al. (25) observed depression in 86% of women with 
endometriosis and pelvic pain compared to 36% of women with endometriosis without pelvic 
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pain. This implies that the experience of pain plays a vital role in the development of 
depression in women with endometriosis.  
Other studies have looked at the relationship between depression and anxiety in 
women with endometriosis and found the two psychological disorders to be correlated (21, 
22, 28, 29). This indicates that in those women with endometriosis who experience anxiety, 
anxiety may be a non-endometriosis-related risk factor for the onset of depression.  
Few studies have explored socio-demographics in relation to depression in women 
with endometriosis (12, 21, 22). Findings on the influence of age on depression are 
conflicting with two studies (12, 21) reporting a correlation between advanced age and higher 
levels of depression, and one study (22) stating that advanced age is related to better mental 
health. Research on the influence of education level on depression is more consistent, with 
studies observing an association between low levels of education and high levels of 
depression (21, 22). This suggests that some socio-demographics are potential psychosocial 
risk factors for depression in women with endometriosis.  
Coping strategies have also been investigated in a small number of studies showing 
that positive coping strategies are associated with lower levels of depression (1, 20), 
suggesting coping strategies may be possible psychosocial risk factors for depression in 
women with endometriosis. 
Objective 
Despite the existing literature demonstrating that endometriosis is associated with 
psychosocial implications such as depression, research findings are conflicting. Furthermore, 
there is sparse research on risk factors for such outcomes. Identifying psychosocial risk 
factors that increase women’s susceptibility to developing depression is crucial for informing 
preventative strategies, including early detection through assessment, and for treatment with 
targeted psychological intervention. Thus, this systematic review and meta-analysis aimed to 
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add to the existing literature by providing an overview of psychosocial risk factors for 
depression in women with endometriosis. Additionally, suggestions for future research and 
clinical recommendations will be made based on the findings from this meta-analysis. 
Methods 
Eligibility Criteria, Information Sources and Search Strategy 
Eligibility criteria 
Studies were eligible for inclusion in the meta-analysis if they met the following 
criteria: (i) the diagnosis of endometriosis was clinically and/or histologically based; (ii) 
depression was assessed using recognised and validated self-report or clinician-based 
measures; (iii) psychosocial risk factors for depression were evaluated (e.g., age, relationship 
status, education, pain); (iv) the psychosocial risk factor examined had been included in at 
least two studies, (v) studies were published in the English language, and lastly; (vi) 
sufficient statistical data to calculate effect sizes was provided. For this study, a psychosocial 
risk factor was defined as any variable relating to psychological or social conditions that may 
significantly contribute to the presence and severity of depressive symptoms.  
Opinion articles, editorials, letters to the editor, commentaries, viewpoints, case 
studies, brief reports, clinical updates, conference abstracts, reviews and qualitative studies 
were excluded. Studies that investigated endometriosis along with other causes of pelvic pain 
were excluded if it was not possible to separately extract endometriosis-related data. Equally, 
studies that grouped multiple psychological disorders were excluded if data on depression 
could not be extracted separately. Additionally, studies were ineligible if they only reported 
data from multivariate analyses (e.g., regression, structural equation modelling) as 
multivariate analyses generate data based on varying combinations of independent and 
dependent variables, making the data incomparable (30).  
Information sources and search strategy 
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A systematic review of five electronic databases (PubMed, PsycINFO, Web of 
Science, CINHAL, and Embase) for the period from database commencement up to 
September 7th 2018, was undertaken to identify articles examining appropriate variants of 
‘endometriosis’ and ‘pelvic pain’ in combination with ‘depression’ and ‘distress’ (See Table 
A, supplementary material). Search terms were tailored according to the indexing processes 
of each database to ensure all potentially relevant articles were identified. Additionally, a 
research librarian was consulted to improve the accuracy and relevance of the search terms. 
Finally, a manual search of the reference lists of included studies was undertaken to identify 
any relevant articles that may have been missed in the initial search.  
Study Selection 
The initial search generated 6798 studies. After the removal of duplicates, 3603 
studies remained. Applying the eligibility criteria to the titles and abstracts excluded 3447 
studies, leaving 156 studies. The eligibility of these remaining studies was assessed by 
reviewing the full-texts against the inclusion and exclusion criteria. This narrowed the pool of 
studies to seven. A manual search of the reference lists of these studies yielded a further two 
studies appropriate for inclusion. This resulted in nine independent studies being included in 
the meta-analysis (see Figure 1). A random subset of 360 potentially eligible studies was co-
screened by the first author (LST) and a second researcher (MO). Interrater agreement was 
high (98%, K=.86, p<.05) (31) with any discrepancies resolved by consensus discussion. 
[INSERT FIGURE 1 HERE] 
Data Extraction 
Adhering to the Preferred Reporting Item for Systematic Reviews and Meta-analyses 
(PRISMA) guidelines (32) and the reporting guidelines for Meta-analysis of Observational 
Studies in Epidemiology (MOOSE) (33), a data extraction sheet was developed and applied 
to each study. The data extraction sheet summarised key information such as (i) sample 
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characteristics (e.g., sample size, age range and mean), (ii) endometriosis characteristics (e.g., 
method used for diagnosis, type of endometriosis, severity of endometriosis, time since 
diagnosis), (iii) study characteristics (e.g., study aim, design, comparison groups, recruitment 
source, measures of depression, measures of psychosocial risk factors), (iv) psychosocial risk 
factors, (v) effect size estimates (e.g., correlations, t-tests, chi-square). Most studies contained 
sufficient data to undertake some analysis. However, in attempts to enable more 
comprehensive analysis, twenty-one authors were contacted to obtain additional data on 
psychosocial risk factors and depression. Four authors (20-22, 34) replied, supplying 
additional data. 
Data extraction was performed by the first author (LST) and verified by a second 
researcher (MO). Seven potential risk factors were identified: age, education, marital status, 
anxiety, chronic pelvic pain, dysmenorrhea and dyspareunia.  
Assessment of Quality  
The Joanna Briggs Institute (JBI) critical appraisal tool for analysing cross-sectional 
studies (35) was applied to assess the reported methodological quality of studies that met the 
eligibility criteria. The extent to which each study addressed the possibility of bias was 
assessed by answering “yes”, “no”, “unclear” or “not applicable” to eight questions 
concerning study design, conduct and analysis. The assessment was carried out by the first 
author (LST) and a second critical appraiser (MO) independently with any discrepancies 
resolved by discussion.  
Data Synthesis 
For this review, the correlation coefficient r was selected as the effect size measure of 
psychosocial risk factors for depression. The correlation coefficient was chosen because it is 
easily interpreted with regards to practical importance as it measures the direction of the 
relationship between a psychosocial risk factor and depression, and the strength of that 
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relationship (36, 37). Six studies reported other test statistics (χ2, t, sample size with an exact 
p-value for an unreported r), which were converted into r (30). Effect size data was then 
recorded and analysed using the statistical software Comprehensive Meta-Analysis Software 
(CMA, Version 3, Biostat Inc., Englewood, New Jersey, USA). Following the 
recommendation of Cumming (38), individual effect sizes were pooled using a random-
effects model of meta-analysis to calculate the mean effect size of a group of studies. This 
model is based on the assumption that the variation between observed effect sizes is 
attributable to differences within individual study designs and subject-level sampling error 
(30). Although the measures of depression used across studies examining the same 
psychosocial risk factor varied, the individual effect sizes were still able to be pooled because 
all of the included measures of depression were standardised and comparable (39).  
In line with Cohen’s guidelines (40), correlations of .10, .30, and .50 were interpreted 
as representing small, moderate and large effect sizes, respectively. To determine the 
statistical significance of the individual effect sizes, p-values and 95% confidence intervals 
(CIs) were calculated. An effect size was considered to be significant if the p-value was less 
than or equal to .05 and the CI did not include zero (38). 
To address the possibility that the findings from this meta-analysis were influenced by 
publication bias, Orwin’s fail-safe Ns (Nfs) were calculated (41). Publication bias arises when 
the results of unpublished and published studies are systematically different from each other 
(41). The Nfs represents the number of unpublished or unidentified studies that would need to 
exist to render the effect size findings of this meta-analysis meaningless (i.e. r < .10). A 
conservative approach was adopted, whereby findings were considered robust when the Nfs-
value exceeded the number of studies contributing to a pooled effect size estimate (i.e. Nfs > 
Nstudies). Generally, a high Nfs-value means it is unlikely that unpublished studies would 
contradict the findings of the meta-analysis (36). 
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In addition, heterogeneity was assessed using the I2 statistic to evaluate the degree of 
consistency in pooled effect size estimates (42). The I2-value represents the percentage of 
observed between-studies variance that can be attributed to an actual difference in effect sizes 
rather than to chance (43). Values of I2 around 2%, 50%, and above 50% indicate low, 
moderate and high heterogeneity, respectively, across individual effect size estimates (44). 
The I2-value is not influenced by low statistical power nor by the number of studies included 
in the meta-analysis (45).  
Data Interpretation 
A number of criteria were applied to assess the importance of the findings in this 
review. A psychosocial risk factor was considered clinically and statistically significant if the 
effect size was (i) moderate to large (i.e. r ≥ .30), (ii) statistically significant (i.e. p ≤ .05; 
95% CIs ≠ 0), and (iii) if the associated Nfs-value exceeded the number of studies that 
contributed to the pooled effect size estimate (i.e. Nfs > Nstudies). Study heterogeneity was 




Nine cross-sectional studies with publication dates ranging from 2006 to 2018 were 
included in the meta-analysis (see Table 1). The studies originated from diverse areas of the 
world: Brazil (Nstudies = 3), The United States of America (Nstudies = 2), Italy (Nstudies = 2), 
Austria (Nstudies = 1), and Russia (Nstudies = 1). Sample sizes ranged from 24 (28) to 214 
participants (23).  
Almost all studies (Nstudies = 8) recruited their participants from only one source; one 
study (12) recruited from two sources. The majority of studies (Nstudies = 7) relied on hospital 
Gynaecology and Obstetrics outpatient units for participant recruitment. One study (28) 
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recruited participants from a patient support organisation (EndoTeens), and another study 
(29) relied on a regional centre for family planning and reproduction. 
Four studies (21-23, 29) included a control group in their study design. Three of the 
studies compared women with endometriosis to healthy controls, while Lagana et al. (23) 
compared endometriosis-affected women to women with benign adnexal diseases. 
 Across the nine studies, four measures of depression were employed. Most studies 
(Nstudies = 7) relied solely on self-report measures of depression, with the Beck Depression 
Inventory (BDI, BDI-II; (46)) being the most commonly used measure (Nstudies = 6). One 
study (29) exclusively utilised a clinician rating scale (the Hamilton Depression Rating Scale 
[HAM-D]; (47)), whereas another study (12) included both a self-report measure (BDI) and a 
clinician rating scale (HAM-D). For this study, the self-report measure of depression was 
used in the meta-analysis. 
[INSERT TABLE 1 HERE] 
Participant characteristics 
The total pooled sample comprised 866 women with endometriosis (see Table 2). The 
age range for endometriosis patients was 18-50 with a mean age of 35.29 (SD = 13.04). For 
those studies that included a control group and reported data on age, the mean age of the 
controls was 34.48 (SD = 10.96). There was no significant difference between the age of the 
endometriosis patients and the control group (p = .54). Only one study (48) stated ethnicity, 
with the majority of the women being Non-Hispanic White (7.5%) compared to Black 
(1.3%). Education levels were reported in six studies (12, 20-22, 28, 48). A slight majority of 
the women (21.9%) for which this data was reported described their highest educational 
achievement as high school, closely followed by women describing university as their highest 
educational achievement (18.7%). A large proportion of the women (46.8%) were in a 
relationship and employed (15.2%) as opposed to being single (12.2%) and unemployed 
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(3.2%). The percentages of women with and without children were somewhat comparable at 
19.5% and 13.7%, respectively. Initial stage (Stage I and II) endometriosis was more 
common (13.4%) than advanced stage (Stage II and IV) endometriosis (11.2%). A few 
women (4%) across two studies (28, 29) reported having a family history of endometriosis, 
while another study (48) reported a history of depression and/or anxiety for some of the 
women (4.7%). Over half of the women (55.5%) experienced chronic pelvic pain, more than 
one-third (37.2%) had dysmenorrhea, and nearly one-fifth (19.2%) experienced dyspareunia 
as a symptom of endometriosis. Among those with pelvic pain, the average duration of pain 
was 11.9 years (SD = 7.2). Only two studies (20, 21) collected data on fertility, with 85 
participants being infertile, representing 9.8% of the pooled patient sample. It was observed 
across three studies (21, 25, 28) that nearly one-fifth of the women (17.8%) received some 
form of medical treatment. Smoking history was recorded in three studies (12, 28, 48) with 
the majority of the women being non-smokers (18.2%) compared to smokers (2.4%). It is 
important to note that data on the different variables was not consistently reported across all 
nine studies. 
[INSERT TABLE 2 HERE] 
Quality Assessment of Included Studies 
The reported methodological quality of the studies was examined using the JBI 
critical appraisal checklist for analytical cross-sectional studies. Results showed that studies 
fulfilled five to seven criteria, with five studies fulfilling seven criteria, three studies fulfilling 
six and one study fulfilling five criteria (see Table 3). All studies except for one (28) reported 
their inclusion criteria. Three studies (22, 23, 28) did not state their exclusion criteria. The 
majority of the studies (Nstudies = 7) described their participants and setting in sufficient detail. 
One study failed to provide information on the setting of their study (21), and another study 
provided sparse participant information (23). All studies relied on laparoscopy for the 
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diagnosis of endometriosis except for one study (22) that reported relying on a histologically 
confirmed diagnosis of endometriosis with no mention of surgery. All studies reported 
confounding variables, often in the form of some demographical data (e.g., age, relationship 
status, education, income). However, only a few studies (21-23) stated the strategies utilised 
to deal with confounding variables. Depression was measured validly and reliably across all 
studies as only validated and recognised instruments were utilised. In all studies, appropriate 
statistical tests were used. 
It is important to note that the JBI critical appraisal checklist can only assess the 
reported methodological quality and not the actual methodological quality of studies. 
Nonetheless, based on the assessment of the reported methodological quality of the included 
studies, no studies were excluded from the meta-analysis. 
[INSERT TABLE 3 HERE] 
Synthesis of Results  
Seven psychosocial risk factors for depression were identified in this meta-analysis. 
Of these, only three psychosocial risk factors (anxiety, chronic pelvic pain, and 
dysmenorrhea) are considered clinically significant according to the criteria adopted in this 
review (i.e. r ≥ .30; 95% CIs ≠ 0; p ≤ .05; Nfs > Nstudies). Effect size estimates varied in their 
magnitude, as discussed below.   
Age 
Three studies examined the relationship between age and depression (see Figure 2). 
Of these, only one study (12) reported a significant but weak relationship between advanced 
age and depression. The overall effect size estimate was very small and non-significant (r = 
0.061, 95% CIs [-.161, .275], Nfs < Nstudies, p = .597), suggesting that age was not a 
psychosocial risk factor for depression. However, this finding should be considered with 
caution as the Nfs statistic was lower than the number of studies included in the analysis, 
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indicating that the finding may be influenced by publication bias. The between-studies 
heterogeneity was considerable (I2 = 69.8%) which would be expected in this clinical 
population. 
[INSERT FIGURE 2 HERE] 
Education 
The individual correlations from two studies that assessed the relationship between 
education and depression were not significant (see Figure 3). However, when pooled 
together, the overall effect size became statistically significant but remained clinically non-
significant (r = -.151, 95% CIs [-.295, -.000], Nfs > Nstudies, p = .050). Notably, only two 
studies contributed to the overall pooled effect, meaning the findings should be interpreted 
with caution. However, Nfs was higher than the number of studies included in the analysis, 
suggesting that this finding is robust. Statistical between-studies homogeneity was found (I2 = 
0%), which could possibly be explained by similarities in study design and population, 
including the use of identical instruments for measuring depression. 
[INSERT FIGURE 3 HERE] 
Marital Status 
Two studies explored the association between marital status and depression (see 
Figure 4). Neither of the studies showed a significant correlation. The pooled effect size was 
also not significant (r = .131, 95% CIs [-.021, .276], Nfs < Nstudies, p = .091), indicating that 
marital status was not a clinically important psychosocial risk factor for depression. However, 
only two studies were included in the analysis, threatening the strength of this finding, which 
is also reflected in the small Nfs statistic. As the same two studies were pooled for education 
and marital status, homogeneity (I2 = 0%) applied for both potential psychosocial risk factors.  
[INSERT FIGURE 4 HERE] 
  
PSYCHOSOCIAL RISK FACTORS FOR DEPRESSION IN ENDOMETRIOSIS 53 
 
Anxiety 
Four studies investigated the relationship between anxiety and depression (see Figure 
5). Highly significant moderate to large correlations were observed across all studies, 
resulting in a large and significant pooled effect size (r = 0.662, 95% CIs [.491, .783], Nfs > 
Nstudies, p < .001). This implies that experiencing anxiety was a clinically significant 
psychosocial risk factor for depression. Substantial between-studies heterogeneity was 
observed (I2 = 71.8%), which could be partially attributable to the use of varying measures of 
depression and anxiety across the studies. The associated high Nfs indicates that a substantial 
number of unpublished studies reporting a non-significant relationship between anxiety and 
depression would need to exist to threaten this finding. 
[INSERT FIGURE 5 HERE]  
Chronic Pelvic Pain 
Six studies assessed the association between chronic pelvic pain and depression. Four 
out of six studies had significant moderate effect sizes (see Figure 6). The overall pooled 
effect size was moderate and highly significant (r = 0.333, 95% CIs [.195, .458], Nfs > Nstudies, 
p < .001), suggesting that chronic pelvic pain was a clinically significant psychosocial risk 
factor for depression. The heterogeneity observed between the studies was considerable (I2 = 
69.4%). Considering the high Nfs statistic, this finding can be interpreted as robust.  
[INSERT FIGURE 6 HERE] 
Dysmenorrhea 
The individual correlations of two studies that examined the relationship between 
dysmenorrhea and depression were moderate and highly significant (see Figure 7). The 
overall pooled effect size was also moderate and highly significant (r = .408, 95% CIs [.236, 
.555], Nfs > Nstudies, p < .001). This implies that dysmenorrhea was a clinically significant 
psychosocial risk factor for depression. The I2 statistic showed reasonable between-studies 
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heterogeneity (I2 = 60.5%), and the Nfs statistic suggests that the finding is robust. However, 
as only two studies contributed to the overall effect size, this result should be interpreted with 
caution. 
[INSERT FIGURE 7 HERE] 
Dyspareunia 
Two studies explored the association between dyspareunia and depression. Both 
studies reported a small but significant correlation (see Figure 8). When the studies were 
pooled, the overall effect size was statistically significant but not clinically significant (r = 
.183, 95% CIs [.065, .295], Nfs < Nstudies, p = .002). Since only two studies were included in 
the analysis, the finding should be interpreted with caution, which is also reflected in the Nfs 
statistic. The Nfs is lower than the number of studies included in the analysis, suggesting that 
this finding may not be robust and possibly influenced by publication bias. 
[INSERT FIGURE 8 HERE] 
Comment 
Main Findings 
This systematic review and meta-analysis investigated potential psychosocial risk 
factors for depression in women with endometriosis. Nine studies were included with a total 
of 866 participants. Seven psychosocial risk factors for depression were identified with three 
of them being clinically significant according to the criteria for this review: anxiety, chronic 
pelvic pain and dysmenorrhea.  
The findings from this meta-analysis suggest that the experiences of chronic pelvic 
pain and dysmenorrhea are clinically important symptoms of endometriosis that can 
significantly affect the emotive functioning of affected women by making them more 
vulnerable to depression. All pain symptoms (i.e., chronic pelvic pain, dysmenorrhea and 
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dyspareunia) were statistically significant. However, only chronic pelvic pain and 
dysmenorrhea were clinically significant psychosocial risk factors for depression.  
 Anxiety demonstrated the strongest relationship with depression with its large 
clinically significant effect size, suggesting that women with endometriosis who experience 
anxiety are more likely to experience depression. This makes anxiety a clinically significant 
psychosocial risk factor for depression.  
Strengths and Limitations 
To the author’s knowledge, this is the first systematic review and meta-analysis that 
has set out to identify potential psychosocial risk factors for depression in women with 
endometriosis. Using multiple search terms in combination with thorough inclusion criteria 
improved the effectiveness and sensitivity of the extensive literature search by increasing the 
possibility of detecting all relevant articles. Considering that potentially relevant articles 
could be missed in databases searches, a manual search of reference lists was carried out, and 
the Nfs was calculated to alleviate the ‘file drawer problem’ to the extent that this statistic 
allows. The review drew on data from different countries, making the findings cross-
culturally applicable and adding to the strengths of the current review.  
Some limitations of the present meta-analysis should be taken into account. Only nine 
studies were eligible for inclusion in this review, with some analyses only including two 
studies. Analyses that only included two studies should be interpreted with caution as these 
findings may be more vulnerable to publication bias. Thus, further primary research on the 
psychosocial risk factors for depression identified in this review is warranted as a larger 
number of included studies could potentially make the findings more robust and/or suggest 
other potential psychosocial risk factors for depression (22). Equally, there would be a great 
benefit in conducting more studies addressing the correlation between endometriosis-related 
factors and depression in order to accumulate robust evidence that can better inform patient 
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care. This includes studies investigating the relationship between depression and time since 
diagnosis, diagnosis delay, endometriosis stage, location of endometriosis, treatment received 
for endometriosis, fertility status, and demographic information. Furthermore, the study 
design of all studies included in the current meta-analysis was cross-sectional, making it 
impossible to make causal inferences. Longitudinal studies are warranted in order to 
determine the temporal relationship between psychosocial risk factors and depression in 
women with endometriosis. The small number of studies included in this review highlights 
the fact that this area is somewhat under-researched, and given the impact on women’s 
wellbeing further investigations are warranted.  
Comparison with Existing Literature 
The pooled effect size for anxiety concurred with the individual effect sizes of the 
four studies included in the analysis (21, 22, 28, 29). All effect sizes indicated that anxiety 
was a statistically and clinically significant psychosocial risk factor for depression. As 
anxiety and depression are known to co-occur in individuals, with the prevalence of anxiety 
and depression comorbidity being approximately 60% (49), it is not surprising that anxiety 
was shown to be a clinically significant psychosocial risk factor for depression.  
Similar consistency in results was observed for dysmenorrhea with both the overall 
effect size and the individual effect sizes of the included studies (20, 21) being statistically 
and clinically significant. This indicates that experiencing dysmenorrhea renders affected 
women more vulnerable to depression.  
The overall pooled result of the chronic pelvic pain analysis is consistent with some of 
the existing literature (20, 21, 25), indicating that chronic pelvic pain is a statistically and 
clinically significant psychosocial risk factor for depression. However, this result contrasts 
the findings of Carey et al. (48) and González-Echevarría et al. (28) as their results did not 
reach statistical significance. Nonetheless, research has demonstrated that chronic pelvic pain 
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has significant adverse effects on women’s mental health and quality of life (1, 13, 26, 50-
53).  
Being statistically significant but not clinically significant, the pooled result for 
dyspareunia was consistent with the results of the individual studies included in the analysis 
(21, 23). Research has shown that women who experience dyspareunia engage in less sexual 
behaviour (13, 54). This could explain why dyspareunia, unlike the other endometriosis-
related pain symptoms, was not a clinically significant psychosocial risk factor for 
depression. Women affected by dyspareunia can avoid experiencing this type of pain, 
contrasting the experience of chronic pelvic pain and dysmenorrhea, which cannot be avoided 
or controlled in similar ways to dyspareunia. 
Neither the individual results of the two included studies exploring the relationship 
between depression and marital status (21, 22) nor the pooled result were statistically or 
clinically significant. This suggests that relationship status does not influence affected 
women’s likelihood of developing depression.  
The research relating to age and depression is conflicting. Unlike the overall finding 
of this meta-analysis, Sepulcri and do Amaral (12) reported a statistically and near clinically 
significant relationship between advanced age and depression. However, similar to the 
overall result of this meta-analysis, Facchin et al. (21) did not find a clinically or statistically 
significant relationship between advanced age and depression. Contrasting the direction of 
the relationship between age and depression in both of those studies (12, 21) and this meta-
analysis, Friedl et al. (22) observed a small albeit non-significant effect of younger age on 
depression. Plausible explanations for a relationship between younger age and depression 
could relate to decreasing hormonal levels with ageing and potentially more time to engage 
effectively in the management of the condition (55). Nevertheless, the pooled data in this 
meta-analysis suggest that age is not a psychosocial risk factor for depression.  
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The pooled result on education just reached statistical significance. However, the 
small effect size concurred with previous research (21, 22) showing that educational level is 
not a clinically significant psychosocial risk factor for depression. 
Conclusion and Implications 
The findings from this systematic review and meta-analysis have implications for the 
research and management of endometriosis. In the process of writing this review, potential 
psychosocial risk factors other than the ones included in the review were identified, e.g., 
fatigue, coping strategies, and sexual functioning. The few studies that investigated coping 
strategies and depression employed incomparable measures of coping and did not report 
sufficient statistics to calculate an effect size. Hence, pooling of effect size data was not 
possible for coping strategies in this review. Equally, studies examining fatigue and 
depression, and sexual functioning and depression, only reported multivariate analyses and 
thus, could not be included in this meta-analysis. Primary research on the relationship 
between depression and each of the following, coping strategies, fatigue, and sexual 
functioning is warranted such that more robust conclusions regarding these relationships can 
be made. 
 Clinical implications resulting from the current review include the importance of early 
screening to accurately identify those at greater risk of developing depression. Screening and 
assessment for depression should not only take place upon diagnosis of endometriosis but 
throughout the continuum of endometriosis management, as some psychosocial risk factors 
(e.g., anxiety) may not be present at diagnosis but may occur later in the course of the 
condition. Through early screening and identification of the presence of anxiety, chronic 
pelvic pain and dysmenorrhea, the risk of depression and its severity may be reduced for 
women with endometriosis. Early identification would allow psychological support to be 
incorporated into an individual woman’s treatment plan. The aim of such a multidisciplinary 
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approach in the management of women with endometriosis should be to reduce the adverse 
impact of endometriosis on the women’s psychosocial wellbeing and consequently, their 
quality of life. 
 In summary, endometriosis is a very complex condition that makes affected women 
more vulnerable to compromised psychosocial wellbeing. Anxiety, chronic pelvic pain, and 
dysmenorrhea were found to be clinically significant psychosocial risk factors for depression. 
These psychosocial risk factors should be considered in the management of endometriosis to 
improve women’s psychosocial wellbeing and quality of life. Further primary research 
investigating the seven identified potential risk factors and other potential psychosocial risk 
factors such as fatigue, coping strategies and sexual functioning along with other 
endometriosis-related factors (e.g., diagnostic delay, location, treatment received, fertility 
status) is warranted in order to draw more firm conclusions regarding potential risk factors 
for depression in women with endometriosis.  
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Characteristics of Included Studies 
Note. Measure Abbreviations: BDI = Beck Depression Inventory; BDI-II = Beck Depression Inventory-II; HADS-D = Hospital Anxiety and Depression Scale-Depression; HAM-D = Hamilton 
Depression Rating Scale. 




Recruitment source Depression Measure Risk Factors Measured 
Carey (2014) United States 79 (79) 
Hospital Outpatient Unit for 
Endometriosis 
BDI Chronic Pelvic Pain 
Donatti (2017) Brazil 171 (171) 









Facchin (2015) Italy 171 (110) 










Friedl (2015) Austria 123 (62) 
Hospital Outpatient Unit for 
Endometriosis 
HADS-D Anxiety 
González-Echevarría (2018) United States 24 (24) 





Chronic Pelvic Pain 
 
Lagana (2015) Italy 214 (166) 
Hospital Outpatient Unit for 
Endometriosis 
The Zung Self-Rating Depression 
Scale 
 
Chronic Pelvic Pain; 
Dyspareunia 
 
Lorencatto (2006) Brazil 100 (100) 
Hospital Outpatient Unit for 
Endometriosis 
BDI Chronic Pelvic Pain 
Nasyrova (2011) Russia 
80 (50) 
 
Regional Centre for Family Planning 
and Reproduction 
HAM-D Anxiety 
Sepulcri (2009) Brazil 104 (104) 
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 Table 2  
Participant Sociodemographic and Endometriosis Characteristics (Nstudies = 9)* 
 
Note. * not all studies provided this data for their endometriosis and control groups. NStudies = the number of studies providing data; NParticipants = the number of participants with endometriosis 
for which data was provided; a Number varies within columns because not all studies reported this information; b Percentage (%) of participants is in relation to the total sample of 
  Endometriosis Patients   Control     Statistical Analysis 
        95% CI  
Variable NStudies a NParticipants 
(%)a,b 
M (SD) Range NStudies a NParticipants M (SD) Range Lower Upper  t df p 
Sample Size 9 866 (100) 96.2 (49.4) 24-171 3** 170 56.7 
(6.13) 
48-61      
Age (y) 7*** 732 35.29 (13.04) 18-50 2 109 34.48 
(10.96) 
Not given -3.39 1.77 -0.62 839 0.54 
Ethnicity              
Non-Hispanic White 1 65 (7.5)            
Black 1 11 (1.3)            
Level of Education              
High school 5 190 (21.9)            
University 4 162 (18.7)            
Technical degree 1 7 (0.8)            
Employment               
Yes 2 132 (15.2)            
No 2 28 (3.2)            
Marital Status              
Partnered/Married 7 405 (46.8)            
Single/Widowed 4 106 (12.2)            
Parous              
Children 3 169 (19.5)            
No children 3 119 (13.7)            
Endometriosis Stage              
I-II 3 116 (13.4)            
III-IV 3 97 (11.2)            
Family History of Endometriosis 2 35 (4.0)            
Pain              
Chronic Pelvic Pain 6 481 (55.5)            
Dysmenorrhea 4 322 (37.2)            
Dyspareunia 3 166 (19.2)            
Duration of Pelvic Pain (yrs) 1 79 (9.1) 11.9(7.2)           
Infertility 2 85 (9.8)            
Receiving Medical Treatment 3 149 (17.2)            
History of Depression and/or 
Anxiety 
1 41 (4.7)            
Smoker              
Yes 2 21 (2.4)            
No 3 158 (18.2)            
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endometriosis patients; M = Mean; SD = standard deviation; 95% CI = 95% confidence interval with lower and upper limits; **Four studies used control groups but one study did not report 
the number of health controls included in their study, therefore only data from three studies are reported.***All studies reported age, however, in one study, it was impossible to separate the 
mean age and standard deviation for patients and controls, and another study only reported the percentage of patients in the age ranges 13-19 years and 20-25 years. 
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Table 3 





























































































































































































































































































































Carey et al. (2014)         Include 
Donatti et al. (2017)         Include 
Facchin et al. (2015)         Include 
Friedl et al. (2015)         Include 
González-Echevarría et al. (2018)         Include 
Lagana et al. (2015)         Include 
Lorencatto et al. (2006)         Include 
Nasyrova et al. (2011)         Include 









Logic Grids for Electronic Database Searches 
PubMed – 1548 
Endometriosis 51469 Depression 534566 
“endometriosis”[mh] OR “pelvic pain”[mh] OR 
“menstruation disturbances”[mh:noexp] OR 
“menorrhagia” [mh] OR “dyspareunia” [mh] OR 
endometriosis[tiab] OR pelvic pain[tiab] OR 
menstruation disturbance*[tiab] OR painful 
period*[tiab] OR heavy period*[tiab] OR painful 
intercourse[tiab] OR dyspareunia[tiab] OR 
dysmenorrhea[tiab] OR menstrual 
disorder*[tiab] OR menstruation disorder*[tiab] 
“depression”[mh] OR “depressive 
disorder”[mh] OR depress*[tiab] OR 
distress[tiab]  
 
PsycINFO - 427 
Endometriosis 1877 Depression 324660 
(menstrual disorders).sh OR dyspareunia.sh OR 
dysmenorrhea.sh OR endometriosis.ti,ab OR 
pelvic pain.ti,ab OR painful period*.ti,ab OR 
heavy period*.ti,ab OR painful intercourse.ti,ab 
OR dyspareunia.ti,ab OR dysmenorrhea.ti,ab OR 
menstrual disorder*.ti,ab OR menstruation 
disorder*.ti,ab 
(depression emotion).sh OR exp major 
depression OR depress*.ti,ab OR distress.ti,ab  
 
 
Web of Science - 1360 
Endometriosis 37399 Depression 667156 
TS=(endometriosis OR “pelvic pain” OR “painful 
period*” OR “heavy period*” OR “painful 
intercourse” OR dyspareunia OR dysmenorrhea 
OR “menstrual disorder*” OR "menstruation 
disturbances" OR menorrhagia OR 
"menstruation disorder*") 
TS=( depress* OR distress) 
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CINAHL – 310 
Endometriosis 6417 Depression 108907 
MH endometriosis OR MH “pelvic pain” OR MH 
“menstruation disorders” OR MH 
dysmenorrhea OR MH dyspareunia OR MH 
menorrhagia OR TI endometriosis OR AB 
endometriosis OR TI “pelvic pain” OR AB “pelvic 
pain” OR TI “menstruation disturbance*” OR AB 
“menstruation disturbance*” OR TI “painful 
period*” OR AB “painful period*” OR TI “heavy 
period*” OR AB “heavy period*” OR TI “painful 
intercourse” OR AB “painful intercourse” OR TI 
dyspareunia OR AB dyspareunia OR TI 
dysmenorrhea OR AB dysmenorrhea OR TI 
“menstrual disorder*” OR AB “menstrual 
disorder*” OR TI “menstruation disorder*” OR 
AB “menstruation disorder*” 
MH depression OR TI depress* OR AB depress* 
OR TI distress OR AB distress 
 
 
Embase - 3127 
Endometriosis 64707 Depression 762235 
Endometriosis/de OR “pelvic pain/de” OR 
“menstruation disorder/de” OR 
dysmenorrhea/de OR menorrhea/de OR 
dyspareunia/de OR endometriosis:ti,ab OR 
“pelvic pain”:ti,ab OR “menstruation 
disturbance*”:ti,ab OR “painful period*”:ti,ab 
OR “heavy period*”:ti,ab OR “painful 
intercourse”:ti,ab OR dyspareunia:ti,ab OR 
dysmenorrhea:ti,ab OR “menstrual 
disorder*”:ti,ab OR “menstruation 
disorder*”:ti,ab 
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Systematic review and meta-analysis studies: please refer to Systematic Reviews  
 
Translational Research: please refer to Translational Research 
Systematic Reviews 
Each article in this category provides a comprehensive and exhaustive systematic review of 
the literature related to the topic, collating all relevant evidence meeting pre-specified 
eligibility criteria. Systematic reviews may not be combined with other manuscript types. 
Systematic reviews must include a clearly stated set of objectives with reproducible 
methodology, a systematic search, eligibility criteria for selecting studies, assessment of 
study quality (risk of bias), an assessment of the validity of the findings and systematic 
synthesis of these findings. Metaanalysis, the use of statistical techniques to combine and 
summarize results across studies, may or may not be contained within a systematic review. 
Authors must adhere to the PRISMA and MOOSE guidelines (for guidance see Editorial 
Policies). 
Systematic Reviews are limited to 5000 words of main text (not counting the title page, 
abstract, condensation, acknowledgments, references, tables, legends, and figures). Include a 
structured abstract containing no more than 350 words and as many alphabetized key words 
or short phrases as needed for indexing. 
Title: The title should identify the report as systematic review or metaanalysis. 
The type(s) of non-human animals or other species used in an investigation must be named in 
the Title, Abstract, and Materials and Methods sections of the manuscript. 
On the next page supply: 
Condensation, Short Title, AJOG at a Glance, and Keywords 
 Condensation - a 1-sentence condensation of the paper, consisting of no more than 25 
words, stating its essential point(s); this sentence, which is subject to copy editing in 
conformance with Journal style, will appear in the Table of Contents. 
 Short Title: a short version of the article title, for the identification line inserted at the 
bottom of each published table and figure. 
 AJOG at a Glance: This section is limited to no more than 130 words, 1-3 short 
sentences or phrases in bullet form, briefly describing your study, its significance, and 
its contribution to the literature. Include the questions followed by your responses, and 
listed in bullet form with A., B., and C., headings (not in paragraph form). All 
responses are subject to minor editorial alterations and/or shortened without the 
authors' approval, and published on the Journal website. 
A. Why was this study conducted? 
B. What are the key findings? 
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C. What does this study add to what is already known? 
 
 Keywords - Keywords are a pertinent component in making articles more visible and 
accessible to potential readers and assist in the dissemination of your research. 
Provide as many alphabetized key words or short phrases as needing for indexing 
purposes. Approximately 10 terms are recommended, but do not duplicate terms or 
phrases utilized in the manuscript title as they are automatically included. 
On the next page supply: 
Abstract: Include a structured abstract containing no more than 350 words in accordance 
with PRISMA guidelines, and with the following headings: 
 Objective 
 Data sources (including years searched) 
 Study eligibility criteria (study design, populations, and interventions [if applicable]) 
 Study appraisal and synthesis methods 
 Results 
 Conclusions 
Main text: Headings and subheadings in the main text should include the following; note that 
subheadings may be modified to best represent the specific report. 
 Introduction (rationale, explain impetus for Review) 
 Objective(s) 
 Methods 
Eligibility criteria, information sources, search strategy 
Study selection 
Data extraction 





Risk of bias of included studies 
Synthesis of results 
 Comment 
Main findings 
Strengths and limitations 
Comparison with existing literature 
Conclusions and Implications 
 
 




Requirements for manuscripts submitted to the Journal generally conform to the Uniform 
Requirements for Manuscripts Submitted to Biomedical Journals from the International 
Committee of Medical Journal Editors (http://www.icmje.org). 
 
Manuscripts must be submitted in American English, double spaced, with a font size no 
smaller than 12. Number pages consecutively in the upper right corner in the following order: 
title page, condensation and short version of title, abstract, main text, acknowledgments, 
references, tables, and figure legends. 
 
IMPORTANT: Figures are to be uploaded individually and in separate files (one figure per 
file). DO NOT embed the figure into the manuscript text file, as this compromises the 
image quality, creating an unpublishable image (see artwork). 
References 
 
Follow the format in the Uniform Requirements for Manuscripts Submitted to Biomedical 
Journals from the International Committee of Medical Journal Editors. http://www.icmje.org 
Standard journal title abbreviations are available in the List of Serials Indexed for Online 
Users from the National Library of Medicine. 
http://www.nlm.nih.gov/tsd/serials/terms_cond.html 
 
Numbering and order 
All references are to be numbered sequentially as they fall in the text. For references that are 
not cited in the main text but only within table(s) or figure(s), begin such numbering after the 
numbers in the main reference list. 
 
Insert citations in Arabic numerals as superscripts, not in parentheses. If the reference follows 
a comma or falls at the end of a sentence, the superscript should follow the comma or the 
period. 
 
Do not include the first author of the cited reference in the text, in parentheses or otherwise, 
except as part of the text itself (Smith et al found…. or In a study by Smith et al, ....). 
 
If any reference is repeated or out of order, the author is responsible for renumbering 
references as needed prior to submission or resubmission. If any reference(s) are added or 
deleted during editing, the author is responsible for renumbering all subsequent references, 
both in citations within the text (and tables and figures) and, correspondingly, in the reference 




In general references follow AMA style.  
 
For up to 6 authors, list all; for 7 or more authors, list the first 3 + et al. 
 
•Journal article 
Nageotte MP, Vander Wal B. Achievement of the 30-minute standard in obstetrics—can it be 
done? Am J Obstet Gynecol 2012;206:104-7. 
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•Book chapter or section 
Kim M. Amenorrhea: primary and secondary. In: Zuspan FP, Quilligan ED, eds. Handbook 
of obstetrics, gynecology, and primary care. St Louis, MO: Mosby; 1998:3-10. 
 
•Personal communications; unpublished data 
If essential, these may be cited, within parentheses, at an appropriate location in the text, but 
not as numbered references. Written, signed permission from individual(s) quoted must 
accompany the manuscript upon submission. 
 
for additional examples see any recent issue of the Journal. 
 
Abstracts 
Abstracts of scientific meetings can be cited; however; once the complete work is published, 
the article citation is preferred. 
 
Journal abbreviations source 
Journal names should be abbreviated according to the List of Title Word Abbreviations: 
http://www.issn.org/services/online-services/access-to-the-ltwa/. 
 
Provisional patent applications 
Provisional patent applications may not be cited as a reference. 
 
Reference links 
Increased discoverability of research and high quality peer review are ensured by online links 
to the sources cited. In order to allow us to create links to abstracting and indexing services, 
such as Scopus, CrossRef and PubMed, please ensure that data provided in the references are 
correct. Please note that incorrect surnames, journal/book titles, publication year and 
pagination may prevent link creation. When copying references, please be careful as they 
may already contain errors. Use of the DOI is encouraged. 
 
References in a special issue 
Please ensure that the words ‘this issue’ are added to any references in the list (and add any 
citations in the text) to other articles in the same Special Issue. 
 
Web references 
Websites may or may not be appropriate sources for citation; e.g., websites that serve as 
repositories of genetic information maintained by NIH, NCI, and the National Library of 
Medicine are acceptable. 
 
As a minimum, the full URL should be given and the date when the reference was last 
accessed. Any further information, if known (DOI, author names, dates, reference to a source 
publication, etc.), should also be given. Web references can be listed separately (e.g., after the 




Submit tables in the manuscript file at the conclusion of the reference list and before the 
figure legends. Create all tables as double-spaced text in Microsoft Word. Any table 
submitted as a *.jpg or *.tif file will be returned for replacement. 
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Identify each table with a brief title (as few words as possible; reserve abbreviations for the 
key) and with an Arabic number (Table 1, Table, 2, etc.) in the order in which it is cited in the 
text. Each column, including the first, must have a heading. Put all explanatory matter in 
footnotes, including the spelling out of any nonstandard abbreviations used in the table. 
 
For footnote symbols within tables, follow the style and order noted on pages 90-95 of the 
AMA style guide, 10th edition. For placement, start in the upper left corner and work across, 
left to right, and down, line by line. 
 
If a table, in whole or in part, was derived from copyrighted material, a footnote at the bottom 
of the table must credit the original source, cited fully. Any copyrighted material must be 





Ensure that each illustration has a caption. Supply captions separately, not attached to the 
figure. A caption should comprise a brief title (not on the figure itself) and a description of 
the illustration. Keep text in the illustrations themselves to a minimum but explain all 




Elsevier accepts electronic supplementary material to support and enhance your scientific 
research. Supplementary files offer the author additional possibilities to publish supporting 
applications, high-resolution images, background datasets, sound clips and more. 
Supplementary files supplied will be published online alongside the electronic version of 
your article in Elsevier Web products, including ScienceDirect: 
http://www.sciencedirect.com. In order to ensure that your submitted material is directly 
usable, please provide the data in one of our recommended file formats. Authors should 
submit the material in electronic format together with the article and supply a concise and 
descriptive caption for each file. For more detailed instructions please visit our artwork 
instruction pages at https://www.elsevier.com/artworkinstructions. 
